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Abstract 
Knowledge of multiscale mechanisms in pathophysiology is the bedrock of clinical 
practice. If quantitative methods, predicting patient-specific behavior of these 
pathophysiology mechanisms, are to be brought to bear on clinical decision-making, 
the Human Physiome community and Clinical community must share a common 
computational blueprint for pathophysiology mechanisms. A number of obstacles 
stand in the way of this sharing - not least the technical and operational challenges 
that must be overcome to ensure that (i) the explicit biological meaning of the 
Physiome’s quantitative methods to represent mechanisms are open to articulation, 
verification and study by clinicians, and that (ii) clinicians are given the tools and 
training to explicitly express disease manifestations in direct contribution to 
modeling. To this end, the Physiome and Clinical communities must co-develop a 
common computational toolkit, based on this blueprint, to bridge the representation of 
knowledge of pathophysiology mechanisms (a) that is implicitly depicted in 
electronic health records and the literature, with (b) that found in mathematical 
models explicitly describing mechanisms. In particular, this paper makes use of a 
step-wise description of a specific disease mechanism as a means to elicit the 
requirements of representing pathophysiological meaning explicitly. The 
computational blueprint developed from these requirements addresses the Clinical 
community goals to (i) organize and manage healthcare resources in terms of relevant 
disease-related knowledge of mechanisms, and (ii) train the next generation of 
physicians in the application of quantitative methods relevant to their research and 
practice.  
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Introduction 
Practicing physicians and surgeons leverage knowledge of pathophysiology 
mechanisms to take clinical decisions. While the physiological community2 generated 
this knowledge as a result of precise quantitative analysis, the pathophysiology-based 
methods employed by the clinical community for the training and practice of 
medicine primarily rely on qualitative approaches (given, for instance, the heavy 
reliance on free text descriptions and static diagrams in both pathophysiology 
textbooks, as well as in clinical record-taking). This divergence in approaches 
between the Physiome and Clinical communities is at the root of considerable loss of 
opportunity to share knowledge and collaborate on the study of pathophysiology 
mechanisms relevant to: 
1) understanding disease processes, in terms of cause and consequence, 
2) developing and re-purposing drugs and devices, as well as  
3) planning diagnostic and therapeutic interventions. 
 
To allay the collaborative handicap caused by the above discrepancy, it is crucial to: 
A. identify the common ground – i.e. the knowledge scenarios in 
pathophysiology that the two communities have in common, 
B. understand the implications of the lack of formal convergence between the 
knowledge management strategies of these two communities, and  
C. provide solutions that improve cross-disciplinary convergence in 
pathophysiology knowledge management. 
 
In addressing points A to C above, this paper identifies and collates the 
representational requirements for the exchange of computer-readable knowledge 
about pathophysiology mechanisms between the Physiome and Clinical communities. 
This blueprint of requirements builds a shared view of pathophysiology mechanisms – 
a view that is consistent and compatible with the operational goals of both 
communities. In the conclusion section, we make recommendations for this blueprint 
as the basis of an open computational toolkit for the management of pathophysiology 
resources in tangible support of cross-disciplinary collaboration. 																																																								
2	The	Physiome	community	is	distinct	from	the	physiological	community.	The	Physiome	community	
has	developed	modelling	and	data	standards,	and	associated	computational	tools	and	repositories,	to	
create	a	reproducible	multiscale	physiological	modelling	framework.	We	will	refer	to	both	the	
physiological	community	and	the	Physiome	community	from	here	on	as	the	‘Physiome’	community.	
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Point A: The common ground 
Knowledge of multiscale anatomy is leveraged by both Physiome and Clinical 
communities to organize knowledge about the: 
1) location of biomedical measurement, and 
2) routes linking locations of measurement. 
 
Both communities develop biophysical models, to a varying degree of formality, that 
take into account correlations between biomedical measurements. In some cases, it is 
important to understand how the route linking the locations of measurement 
contributes to the correlation. In addition, mathematical depictions of biophysical 
mechanisms, in both normal physiology and pathophysiology, may be represented in 
terms of rates of transfer over these routes.  
 
Furthermore, both communities take into account the creation, destruction and 
alteration of routes as leveraged by the body to regulate rates of transfer over a wide 
range of physical dynamic systems, for instance in: 
1) Normal Physiology 
i. immune system (e.g. the puncturing of cytosol-to-extracellular 
connections by the complement cascade to eliminate virus-infected and 
cancer cells, the repair of blood vessel leakage by coagulation), 
ii. cell signalling and metabolism (e.g. endocrine and exocrine cells fuse 
internal vesicles to plasma membrane to transfer secretory substances to 
the outside of the cell), 
iii. pumps/channels (e.g. connectivity route of urinary bladder to the outside 
is reversibly altered by pelvic sphincters for the purpose of waste 
elimination; voltage-gated of ion channels across the phospholipid 
bilayers), 
iv. development (e.g. the growth of the septum transversum – precursor to 
the diaphragm - that establishes a topological separation between the 
thoracic and abdominal cavities; the fusion of left and right endocardial 
tubes to form the primitive heart; intussusceptive angiogenesis in the 
creation of new blood vessels). 
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2) Pathophysiology 
i. infection (e.g. filariasis infestation leading to blockage of lymphatic 
channels, helicobacter pylori causing gastric ulcer perforation leading to 
abnormal communication between the stomach lumen and blood vessel 
lumen), 
ii. metabolic accumulation (e.g. atherosclerosis leading to mycardial 
infarction due to coronary artery blockage or artic valve regurgitation, and 
gallstone formation leading to acute pancreatitis due to blockage at the 
Ampulla of Vater, excessive communication between the dermis and the 
outside environment due to keratin/keratinocyte-adhesion weakness in 
epidermolysis bullosa and pemphigus vulgaris respectively; aortic valve 
incompetence due to atherosclerosis causing regurgitation between the left 
ventricle and the aorta), 
iii. external trauma (e.g. axonotmesis of the median nerve due to carpal 
tunnel syndrome, intestinal obstruction due to incarcerated hernia, 
fractured ribs causing an abnormal communication between the pleural 
space and the outside air in traumatic pneumothorax), 
iv. toxicity (e.g. tetrodotoxin poisoning leading to muscle paralysis due to 
blockage of fast voltage-gated sodium channels, cholera toxin results in 
diarrhoea due to massive salt and water secretion across the intestinal 
epithelium), 
v. congenital malformations (e.g. obstruction of the foramina of Luschka 
leading to hydrocephalus due to decrease in ventricular cerebrospinal fluid 
outflow, post-partum patent ductus arteriosus and atrial septal defect 
leading to abnormal pulmonary-artery-to-aorta and left-atrium-to-right-
atrium communication respectively). 
 
3) Therapeutic Intervention 
A number of therapeutic modalities seek to rectify disease conditions 
through the manipulation of anatomical routes. A number of drugs, for 
instance, directly affect membrane channels (e.g. Amiodarone blocking both 
sodium and potassium channels in the myocardium, omeprazole inhibiting 
the proton pump in the epithelium of the stomach) or the patency of vessels 
(e.g. adrenergic decongestants reduce respiratory mucosal hyperaemic 
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swelling and mucus production). In addition, there is much in the practice of 
surgery that consists of topological operations at a macroscopic level (e.g. a 
Roux-en-Y anastomosis that creates end-to-side route between stomach and 
jejunum or ileum, repair of gastric ulcer, coronary artery bypass graft). 
 
The common ground between Physiome and Clinical communities for the 
representation of pathophysiology mechanisms, therefore, consists of the application 
of topological concepts to describe routes of transfer across multiscale anatomical 
compartments. Two of the key obstacles for interoperability between the two 
communities are the lack of: 
1. a formal and shared topological reference map over which representations of 
mechanisms by Physiome and Clinical communities can be linked, together 
with 
2. agreed methods and communal tools to describe the location of measurement 
in terms of this map. 
 
The implications of these obstacles are discussed in the next section.  
Point B: Lack of convergence 
Considerable effort has been invested by: 
a) the Physiome community to ensure that the mathematical description of 
pathophysiology process correlations is formalized, standardized and 
shareable (e.g. models in CellML (1) and SBML (2)), and 
b) the Clinical community to develop shareable topographical models of anatomy 
for the interpretation of histological and radiological data (e.g. (3)(4)), as well 
as shareable data models for healthcare data management (e.g. (5)). 
 
However, the above investment has a somewhat limited effect on the consistent 
bridging of [i] the physiological meaning of mathematical models of processes to [ii] 
the physiological meaning of histological, radiological and healthcare models.  
 
Multiscale anatomical knowledge of measurement location, and routes linking such 
locations, is not formally described and shareable between the two communities. 
Developing a formal topological representation of biological structure across multiple 
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scales to address the above shortcoming is a considerable challenge. While, for 
instance, substantial investment by the Systems Biology community has gone into the 
clear cataloguing of well-characterized compendia of relevant biological structures 
(i.e. proteins (6), small molecules (7) and subcellular locations (8)) that participate in 
molecular mechanisms, the unmanageable size of the combinatorial space bearing 
every possible anatomical compartment has severely curbed the ability of any single 
structural model of multiscale anatomy to enumerate them all.  The challenge for the 
Physiome and Clinical communities remains, therefore, to provide the means to 
systematically map the anatomical location of a wide range of measurements. The 
following scenarios indicate some of the shortcomings to be surmounted: 
a) Clinical: 
i. Pharmaceutical – linking tissue data to pharmacokinetic models  
The pharmacokinetic (PK) modeling of processes of drug absorption, 
distribution, metabolism and elimination (ADME) is a core component 
in drug discovery and development. In physiology-based PK modeling 
(PBPK), account is taken of the key anatomical sites responsible for 
ADME functions, as well as the routes by which these sites 
communicate. Some examples of hand-drawn schematics showing key 
PBPK variables and rates of transfer over relevant anatomical 
compartments are depicted in Figure 1. A key bottleneck in the 
development of PBPK models is sourcing of data about measurements 
of gene expression (e.g. (9)) and drug permeability (e.g. (10)(11)) for 
tissues, relevant to the modeling of (i) drug effect/toxicity, and (ii) 
blood-to-tissue drug transitions in ADME.  
Shortcoming: there is currently no provision for the systematic and 
formal recording of anatomical location relevant to ADME PBPK 
model variables, gene expression or drug permeability. 
ii. Surgical – management challenges in patients with diabetes 
mellitus 
Diabetes mellitus (DM) complications interfere directly with drug 
ADME. Specifically, relevant complications include the following 
departures from normal ADME function (12)(13):  
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• Absorption: post-prandial blood pooling, stasis of stomach and 
gallbladder, intestinal hurry due to oversecretion or bacterial 
overgrowth in the small intestine, constipation,  
• Distribution: redistribution of blood volume, altered drug-to-
plasma protein binding, and changed volumes of drug 
distribution,  
• Metabolism: the ability of the liver to produce plasma protein 
(e.g. albumin) and to metabolize drugs is impaired, as well as 
• Elimination: impaired biliary and renal function that impact on 
drug biotransformation and excretion respectively.  
Shortcoming: the lack of a coherent representation of the routes over 
which ADME processes are hampered in DM is a key reason why 
pharmaceutical development of drugs does not take into account the 
wide alteration in ADME that typifies patients with DM. DM patients, 
therefore, are vulnerable to therapeutic errors and drug interactions 
because of this shortcoming. 
b) Physiome - bridging data and model variables  
The Physiome community have developed repositories to manage the storage 
and serving of models and data (e.g. (14)).  However finding data that is 
relevant to a particular model is still a considerable challenge. For example, 
data from anatomical sites relevant to blood pressure regulation need to be 
semantically matched to the variables in mechanistic models of hemodynamic 
control (e.g. (15)(16)). In particular, the challenge is to link: 
i. data such as blood pressure in the lumen of the segment of internal 
carotid artery containing the carotid sinus (Table 1., measurement A), 
rates of secretion of adrenalin from chromaffin cells in the adrenal 
medulla (measurement B), and rates of secretion of renin from granular 
cells in the juxtaglomerular apparatus in the kidney (measurement C), 
and 
ii. equation-linked variables from the Guyton model of circulation control 
(17)(18) as depicted in Figure 2 and further explained in Table 1.  
Both data and model variables are a type of measurement that is ascribed to a 
particular anatomical location. Identifying a functional link between the above 
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data and variables, therefore, requires the automated comparison of location 
knowledge for the measurements (i.e. data and variables) outlined in Table 1. 
A corresponding schematic that attempts to relate the locations of these 
entities in terms of anatomical routes relevant to the mechanisms of blood 
pressure control is shown in Figure 3.  
Shortcomings: 
a. the locations listed in Table 1 are described in free-text and, as such, do 
not provide not computer-readable knowledge supporting the inferencing 
of anatomical routes bridging these sites. The quality of these location 
descriptions, while very high to the human reader, is of limited utility to 
the automated management and integrative goals of an electronic 
repository for physiology modeling resources.  
b. similarly, while it was possible to manually develop Figure 2 to suggest 
the functional relationship between measurements and model variables, the 
means to automatically generate such circuitboard diagrams of anatomical 
routes given the locations in Table 1 as input, to our knowledge, does not 
exist. 
 
To allay the above shortcomings, the next section focuses on the step-wise depiction 
of a specific pathophysiology mechanism to elicit the representational requirements 
for the recording of (i) the location of measurements, and (ii) the routes over which 
processes responsible for the correlation of these measurements unfold. 
 
Point C: Requirements for pathophysiology knowledge management 
This first part of this section describes the biological steps in the pathophysiology 
mechanism of hydronephrosis caused by calculus obstruction of the ureter. In the 
second part, this biological description is converted into a graph linking the locations 
of measurements, relevant to the evolution of this pathology, over an anatomical route 
that accounts for the correlation between measurements. Generalized representational 
requirements for a database of pathophysiology pathways are discussed in the third 
part.  
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1) The pathophysiology of hydronephrosis 
There are a number of conditions (19) that lead to urinary solutes precipitating out of 
solution to create calculi, for instance: 
a. Dehydration, which increases the concentration of all solutes due to the 
kidneys’ attempts to reduce the amount of water lost to urine; 
b. Secretory: certain urinary membrane channels may oversecrete a lithogenic 
ion (e.g. calcium, oxalate) or undersecrete an ion that keeps lithogenic ions in 
solution (e.g. magnesium, citrate); 
c. Sustained metabolic changes: e.g. altered diet or therapy (such as cancer 
chemotherapy, loop diuretics, carbonic anhydrase inhibitors) that increase the 
production of lithogenic solutes (e.g. urate) that have to be eliminated by the 
kidney; 
d. Inflammation (e.g. due to infection or autoimmune insult), which causes 
mucus proteoglycans to be excessively secreted into urine. The presence of a 
stone further increases epithelial irritation/inflammation and overlying 
infection; 
e. Strictures to urinary outflow (e.g. scarring of epithelial tube due to 
inflammation) leading to urinary stasis (i.e. more time for a solute to 
precipitate out of solution) and bacterial overgrowth (i.e. more mucus 
secretion); 
 
The calculus formation, therefore, increases the likelihood of further stone accretion 
by stimulating conditions #d and #e above. The growth of a stone in the pelvicalyceal 
region of the urinary tract provides the right conditions for a calculus to reach to a 
size that cannot be subsequently conveyed down the ureter (20). Such an accretion 
becomes lodged at the pelviureteric junction, reducing urinary outflow. This flow 
reduction is followed by a build up of upstream pressure as the nephrons in that 
kidney continue to produce urine. This urinary pressure build up goes on to compress 
the blood supply of the kidney in the hilum, leading to vascular strangulation and 
subsequent atrophy of that organ. 
 
2) Formal representation of cause and effect in the hydronephrosis scenario 
The above informal account of the pathophysiology mechanism of hydronephrosis 
implicitly describes a number of correlations of rate and state measurements drawn 
	 10	
from a range of locations along and across the renal epithelial (i.e. urinary tract) and 
endothelial (i.e. blood vessel) conduit systems. Therefore, we look to the basic 
geometric configuration of these conduit systems to motivate the organization of 
structural knowledge about the location of these measurements. The basic 
organizational features that need to be taken into account to represent routes linking 
measurement locations are that: 
iii. key biophysical interactions regulating the constitution, as well as the flow, of 
fluid in the lumen take place between the Wall (W) of the conduit and the 
Content (C) contained by the same conduit – two basic types of location, 
therefore, need to be distinguished: (C, W); 
iv. transfers between conduits systems transit through the connective tissue ‘glue’ 
that organizes bundles of endothelial, epithelial and neural conduits; 
v. the representation of long range material transfers (i.e. beyond the range of the 
diffusion limit) must take into account the topology of conduit arborisations to 
explicitly link tube types from different material properties that communicate 
along the same conduit system (e.g. ipsilateral nephrons and ureter). 
 
The type of biomedically relevant measurement in the above scenario is of two kinds: 
the state property of some Material (M) or the rate property of some Process (P). At 
the very least, therefore, there are four distinct types of located measurement entities, 
symbolized as follows: PW, PC, MW, MC. 
 
In this pathophysiology scenario, correlations of located measurements can be 
biophysically modeled over the six equations below (numbered I to VI). These 
functional relationships define transfers taking place within C, within W or across 
CW, as follows: 
 
I. The changing composition of urine; precipitation of salts  
The concentration of various biochemical substances in urine, such as calcium, urate, 
phosphate, etc ( , i=1,2…), changes with time at rates… 
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…dependent on various biochemical processes. At some point an ion such as calcium 
(concentration ) supersaturates and precipitates out of solution, at which point a 
kidney stone begins to form. 
 
II. Formation of calcified material 
The mass of calcified material, , accumulates at a rate… 
  
…dependent on the rate of decrease of calcium in solution ( ) and other factors 
such as inflammation ( , e.g. due to infection or irritation), which causes mucus 
proteoglycans to be excessively secreted into urine.  
 
III. Changing flow in the ureter 
Flow in the ureter, , depends on the diameter of the ureter at the point of stone 
formation ( ), the mass of the kidney stone ( ), the filtrate flow rate 
( ) and the viscosity of urine ( ): 
  
If the stone grows large enough to block the ureter, the flow will stop, but the 
consequences of stone formation is felt upstream well before this point is reached. 
 
IV. Distension of the renal calyces and the renal pelvis   
The difference between filtrate flow ( ) and flow in the ureter downstream of 
the stone ( ) is absorbed by distension of the renal calyces and the renal pelvis 
(which have a total volume ): 
  
The fluid pressure in this space ( ) depends on both the volume  and the elasticity 
 of the surrounding tissue: 
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V. Pressure in the surrounding tissue 
The pressure  in the surrounding tissue depends on the pressure  in the renal 
calyces and the renal pelvis and on the elasticity  of the tissue:  
  
 
VI. Compression of the renal vasculature   
The increasing pressure in the surrounding tissue  compresses the renal vasculature 
and increases the resistance to arterial blood flow , which also depends upon 
geometric and material properties  of the vascular wall and the pressure  in the 
blood: 
  
 
The above relations provide the topology of a graph of C- and W-located M and P 
measurements depicting the key types of transfer relevant to the pathology of 
hydronephrosis. A schematic illustration of this graph is shown in Figure 4. The 
direction of the arrows in this figure indicates the implied causal influence from RHS 
to LHS of equations I to VI. This graph also provides two examples of long-range 
transfers, namely: 
a. (Fig. 4A) between conduit systems: the compression of renal vessels by the 
expanding pelvicalyceal conduits in the renal hilum is depicted in the 
sequence of transfer of pressure from the urinary fluid in the pelvis and 
calyces to the tissue fluid in the connective tissue linking blood vessels to the 
urinary tubing, subsequently compressing renal vasculature thereby reducing 
blood flow. 
b. (Fig. 4B) along a conduit system:  the flow of urine from kidney to bladder is 
represented over three distinct locations, namely: (i) nephron and collecting 
systems, (ii) ureter, and (iii) ureterovesical junction. These contiguous 
locations represent the entire epithelial tract connecting Bowman’s capsule to 
bladder. 
 
The edges of the above graph represent pairwise transfers from one location to 
another. To determine the route between the two locations, however, an 
independent computer-readable topological model of kidney structure is required 
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to determine if, at the level of granularity of this model, the two locations are 
contiguous. If the two locations share a border according to the structural model, 
then the route for transfer consists of the union of the two contiguous locations. If 
there is no contiguity between the two sites, then path-finding calculations over 
the structure of kidney conduits is necessary to determine path through other 
contiguous locations that constrain the transfer. 
 
3) Blueprint: generalized requirements for pathophysiology pathways 
So far, we have described a graph of transfers relevant to the mechanism of a single 
pathology. On a more general level, Point A above outlined a spectrum of transfer 
scenarios drawn from normal physiology as well as disease. As this spectrum of 
physical dynamic systems are also amenable to interpretation and representation in 
terms of energetic operations, the provision of a coherent computational blueprint to 
record these graphs is a key first step to developing a resource of physiology and 
pathology mechanisms shared by the Physiome and Clinical communities. The 
development of a Resource for Pathophysiology Mechanism (RPM) needs to address 
the following high-level requirements in its blueprint: 
a. The RPM will manage: 
i.  knowledge about anatomical location for the annotation of located 
state and rate measurements, and the routes of transfer that link these 
measurements; 
ii. information about experimentally or clinically determined correlations 
of sets of measurements that are to be represented as transfers; 
iii. documentation and provenance data about publications or peer-
reviewed mathematical models from which the above correlations are 
derived; 
b. At the core of the RPM , there must be an open and independent topological 
model of multiscale anatomy that provides formally-represented knowledge of 
different conduit systems (e.g. epithelial, endothelial and neural, as discussed 
in (21)). This model must: 
i. supply location knowledge across any scale for the annotation of 
state/rate measurements; 
ii. contain a reference communication map of standard transfers for the 
principal hydraulic systems for body fluids, such as: blood, lymph, 
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cerebrospinal fluid, urine, bile, chyme/chyle, pulmonary air, tissue 
fluid and cytosol; 
iii. support the representation of population variation in the arborisation 
patterns of the above hydraulic and pneumatic systems; 
iv. semantically link locations with community-supported reference 
ontologies of biological structure (e.g. (22)(23)(24), see also (21) for a 
fuller discussion of key semantic standards) to ensure interoperability 
with external community resources; 
v. be amenable to automated inferencing that enable the calculation of 
transfer routes, given a pair of locations from measurements that 
correlate; 
An implication to points iv and v above is that any external data that is already 
annotated with standard reference ontologies will be, from inception, 
compatible with this topological model. The ontology-based annotation of 
legacy data that is currently not annotated by any ontology will be incentivized 
given the added benefits of finding novel communication relationships 
between locations previously not achievable by inferencing directly over the 
standard reference ontologies. 
 
c. Provide a formalism for the representation of transfer between anatomical 
locations that is able to address both the quantitative character of mathematical 
correlations as well as the qualitative character of located measurement 
defined against the reference model. One such formalism under investigation 
is the Bond Graph approach, which also allows for a graphical representation 
of a physical dynamic system (e.g.(25)(26)(27)(28)). A current difference is 
that the edges indicating transfer in Fig. 4 are unidirectional, while the Bond 
Graph formalism expects transfers to be bi-directional. 
d. The RPM must provide shared and open tools for the two communities to: 
a. maintain and contribute knowledge to the topological model of 
multiscale anatomy; 
b. maintain and contribute transfer graphs representing documented 
correlations between located state/rate measurements; 
c. infer routes between anatomical location and visualize relevant 
knowledge from the topological model of multiscale anatomy and 
transfer graphs; 
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d.  link to external resources such as disease terminologies, gene 
expression data or mathematical models in community repositories. 
In practice, the technical solution may take the form of an application program 
interface (API) for core methods that articulate and maintain the topological 
model, such that calls to this API can be embedded within specialist tools 
serving either community. 
 
Conclusion 
 
The biomedical meaning of electronic health record (EHR) content is organized using 
disease terminologies such as SNOMED-CT (29)(30). One avenue of semantically 
bridging the biomedical meaning of Physiome models with that of EHRs is to develop 
a map between disease terms and variables in process models. The hydronephrosis 
(SNOMED-CT ID D7-14106) scenario is just one example of the definition of a 
standard disease entity in terms of a transfer graph of located measurements. While 
the manual curation of a single disease mechanism is achievable, the coherent 
coverage of pathology mechanisms over the entirety of the SNOMED-CT disease 
terminology requires both a community collaborative effort, together with the 
appropriate tools to effect such collaboration. The requirements collected in this work 
set out the blueprint of such a toolkit. The implementation of such a blueprint will 
provide a key means for the Clinical community to explicitly contribute and collect its 
knowledge about pathophysiology mechanisms to improve the integration of 
Physiome models in for training and healthcare decision support. 
The implementation of the blueprint will be discussed in our future work. 
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FIGURES 
 
Figure 1. Three schematics for the anatomical routes relevant to the absorption, 
distribution, metabolism and elimination of (A) Propofol [diagram from (31)], (B) 
Valproic Acid (32) and (C) Docetaxel [diagram from (33)]. 
 
 
Figure 2. An example of a connected dependency series of six variables (rounded 
boxes) extracted from the Guyton 1992 model, linked via five equations (circles). 
Independent variables are linked to equation nodes via input arrows, dependent 
variables via output arrows (therefore, PRA is both an independent variable to Eq2 
and a dependent variable to Eq1). Each equation may involve more than one 
independent variable (hence the dotted vertical arrows). The free-text definition 
associated with each variable symbol has been copied verbatim from the available 
documentation of the original model.  
 
 
Figure 3. A sketch of depicting cardiovascular and neural anatomical routes between 
functionally-related compartments involved in conveying the interaction between 
measurements A, B and C as well as model variables VRE, PRA, ANPR2 and 
AAR (shown in pink, see also Table 1). Here, compartments are represented in the 
shape of either boxes (e.g. adrenal medulla) or connecting lines (e.g. Vagus Nerve). 
The drawing of symmetrically duplicated compartments (e.g. right and left kidneys) 
was avoided in this diagram to reduce complexity of illustration. The following 
references were used in building this circuit: (34), (35), (36). 
  
 
 
Figure 4. A transfer graph for the hydronephrosis pathophysiology scenario. The 
nodes in the graph consist of located measurements. The main types of measurement 
are Process rate (P) or Material state (M). The type of biophysical (e.g. pressure, 
mass) measurement is depicted in red in the top right corner of the node symbol. In 
the bottom right, the location of the measurement is indicated geometrically as 
conduit Wall (W) or Content (C), as well as in more detail in free text (red). The 
direction of the edges (green) indicates the location with respect to the equals sign in 
equations I to VI, from RHS to LHS. The subgraphs highlighted by regions A and B 
are discussed in the text. A mapping between the above nodes and the variables in 
equations I to VI is provided in Figure 5. 
 
 
 
Figure 5. A mapping between the above nodes and the variables in equations I to VI. 
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TABLES 
 
Dataset	or	
Variable	
Anatomical	Compartment	
A	 The	portion	of	blood	in	the	lumen	of	the	segment	of	internal	carotid	arteries	containing	carotid	sinuses.	
B	 The	entire	pool	of	chromaffin	cells	in	both	adrenal	medullas.	
C	 The	entire	pool	of	granular	cells	in	juxtaglomerular	apparatuses	in	both	kidneys.		
VRE	 The	portion	of	blood	contained	in	the	right	atrium.	
PRA	 The	portion	of	blood	contained	in	the	right	atrium.	
ANPR	 The	entire	wall	of	the	right	atrium.	
ANP	 Plasma	membrane	of	myocardial	cells	in	both	atria.	
ANPC	 The	entire	pool	of	blood	plasma.	
AAR	 The	entire	pool	of	afferent	arterioles	in	both	kidneys.	
Table	1.	A	map	linking	physiology	data	and	variables	(see	Figs	2	&	3)	to	their	respective	anatomical	compartments	of	these	located	measurements.	
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